NORTHPOND VENTURES III GP, LLC purchased 450K shares of KYVERNA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $9.90M. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/12/2024ACC: 0000950170-24-014000
10% Owner
Since Feb 2024
-9.51M
Net shares
Net seller
$9.90M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
3.26M acquired · 12.77M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+2.81M
Price / share
—
Trade value
—
% of position
New position
2/12/2024
0.00→2.81M
Common Stock
Indirect
Shares
+450K
Price / share
$22.00
Trade value
$9.90M
% of position
New position
2/12/2024
0.00→450K
Total
Net shares
+3.26M
Net value
$9.90M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/12/2024 | C · Conversion | +2.81M | — | — | New position | 0.00 | 2.81M |
| Common Stock Indirect | 2/12/2024 | P · Purchase | +450K | $22.00 | $9.90M | New position | 0.00 | 450K |
| Total | +3.26M | $9.90M | ||||||
Derivative Transactions1
Series B Preferred Stock
Indirect
Converts to
Common Stock
2.81M shares
Shares
−12.77M
Strike price
Held after
0.00
Exercisable
—
2/12/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock2.81M shares | 2/12/2024 | C · Conversion | −12.77M | — | 0.00 |